Back the only brand that grades the science and sells the products.
PEPHORMIA is a live, compliant peptide & hormone business with three revenue streams. We're opening a small partnership round — a handful of aligned partners who grow with it. This page is the story; the terms are shared privately on request.
Why us — and why no one else does this
Nobody combines graded, cited education with commerce across topicals + digital + print.
The evidence-grading platforms (like Examine) grade the science but sell no product. The skincare brands (The Ordinary, NIOD) sell product but grade no evidence — they reach for claims. PEPHORMIA does both: every product sits on top of honestly-graded, cited research, and the same trusted core powers cosmetics, digital guides and print. That combination is the moat — hard to fake, hard to copy, and exactly what a distrustful, overwhelmed audience is searching for.
The landscape, honestly mapped
Real brands, real positioning. We sit at premium quality and fair price — and we're the only one spanning education, digital and print alongside the topical.
| Brand | Copper-peptide serum (typical) | Graded evidence | Digital guides | Print / POD | Position |
|---|---|---|---|---|---|
| The Ordinary | ~A$40 / 30ml (1%) | — | — | — | Budget commodity, claim-led |
| NIOD | ~A$70–90 / 30ml (1%) | — | — | — | Premium, science-styled |
| Vitali | ~A$60+ (2–3%) | — | — | — | High-strength, US premium |
| Neurogan / ANAIRUI | ~A$16–30 | — | — | — | Budget, volume |
| Examine.com | No products | Yes | Yes | — | Evidence only, no commerce |
| PEPHORMIA | A$44 / 30ml (1%) | Yes | Yes | Yes | The only all-four combination |
Premium formula, fair price
1% GHK-Cu at A$44 — NIOD quality positioning without the NIOD price, and above budget commodities on formulation and honesty.
Built to survive review
Cosmetic-grade, INCI-named, appearance-only. No therapeutic claims — so products stay sellable and ads stay approvable where rivals get flagged.
A 20+ year AU business
Operated under an ABN active since 2003, GST-registered, ASIC-registered business name. Real, accountable, Australian.
The growth engine — a weekly content flywheel
One trusted evidence core, repurposed across five channels every week. Each feeds the next; the newsletter is the owned asset everything converts into.
Founder POV + graded science. Builds credibility and B2B / partner reach.
Short, honest human replies in niche subs. Trust and search-indexed depth.
TikTok / Shorts
Daily AI short-form. Top-of-funnel hooks that test what converts, cheaply.
Blog
Cited cornerstone articles. The evergreen engine that compounds in search.
Newsletter
Beehiiv list. Where readers become buyers — the asset we own outright.
| Channel | Cadence | Job |
|---|---|---|
| TikTok / Reels / Shorts | Daily (AI-generated) | Discovery + hook testing |
| 3× / week | Authority + partners | |
| 3–5× / week | Community trust + long-tail SEO | |
| Blog | 1–2× / week | Cornerstone SEO |
| Newsletter | Weekly | Nurture → sale |
A small, private round
Real equity, weekly transparency, a fair independent-valuer exit after six months. The binding terms live in a private brief — request it and we'll talk.
Structure at a glance
Request the brief
The full partnership MOU — terms, structure options and the growth plan — is shared privately with genuinely interested partners. It's a private offer, not a public solicitation.
Open the partnership brief → Talk to Raj →